Telehealth startup Medixine raises £2.4M to shorten treatment queues and speed up access to healthcare
The COVID-19 pandemic has dramatically increased the need for remote healthcare solutions as healthcare service providers have been forced to adopt new, modern solutions at an accelerated pace.
Meet Medixine, a telehealth provider that has built an all-in-one digital platform for virtual care to support healthcare professionals focusing better on the patients.
Recently, the Espoo-based company raised €2.9 million (approx £2.4 million) in funding led by a crowdfunding campaign organized by Springvest.
The Finnish company will use the funding to expand its operations in the UK and Central Europe. Further, it plans to develop new products within the Medixine Suite.
The Medixine Suite consists of all the necessary tools including, video appointments, a chat function, messaging, health questionnaires, and remote health monitoring, and automated screening for any illness or condition at any stage.
Established in 2000, the company helps healthcare professionals prioritise resources for patients that need urgent care. The up-to-date information from remote patient monitoring allows healthcare providers to decrease unnecessary doctor’s appointments and shorten a patient’s stay at the hospital.
Covers 2.5M patients, working with NHS
At present, the Medixine Suite covers 2.5 million patients, with customers in the United Kingdom, Spain, Portugal, Finland, and Denmark.
It has clients including Nestlé Health Science, the UK’s National Health Service (NHS), the Finnish Student Healthcare Service (FSHS), Linde, which is a leading global industrial gases and engineering company, and the northern and southern hospital areas of Denmark.
“At the same time, there is a strong global trend for more customised, preventative healthcare in almost all age groups. Healthcare centers and hospitals are gettingmore and more patients who have high expectations for their healthcare. The COVID-19 has further accelerated the need for telehealth solutions.,
“Consequently, Medixine Suite’s offers to care for and monitor patients with any illness or condition,” says Lasse Rousi, CEO of Medixine.
“Medixine’s business is growing due to the advancing digitalisation of healthcare. In the future, an increasingly significant amount of public funds will continue to go towards healthcare. Making sure that healthcare runs smoothly and efficiently will benefit all of us,” says Pauli Marttila, Sitra’s Senior Lead, Venture Capital and Risk Management.
“Instead of trying to cover all issues in a single solution, Medixine’s product is a platform that can be used to build services for most telehealth needs. As an investment, Medixine is a chance for us to take part in the change of healthcare in Europe. It would be great if Medixine’s platform were used to build easy telehealth solutions that shorten treatment queues and speed up access to care,” says Sakari Pihlava, General Partner at Vendep Capital.
“Medixine has helped us to provide comprehensive remote care for families with dementia. Their platform is very intuitive and easy to use”, says Louise Rogerson, COO and Founder at Howz, a company supporting the NHS with a monitoring service that aims to keep dementia patients safe during the pandemic.
”Medixine has a strong background in connected care through its first fifteen years as a consultancy company. By providing large scale and up to national scale bespoke solutions in several countries, including the UK, France and, Finland, our team learned invaluable lessons with hundreds of thousands of users,” says Dr Tapio Jokinen, Founder, and Chair of the Board.